Mainstream

Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance

Biodexa Pharmaceuticals announces 1-for-10 reverse ADR split to regain Nasdaq compliance

Post ContentbdrxRead More

You might also be interested in reading Active user wallets on Ethereum DeFi have dipped 40% in one month.

July 15, 2025
In Mainstream